Methods And Compositions For Detecting And Modulating An Immunotheraphy Resistance Gene Signature In Cancer

Application No.
PCT/US2018/025507
Broad Case No.
BI-10167
Inventors

Benjamin Izar, Livnat Jerby, Aviv Regev, Asaf Rotem, Orit Rozenblatt-Rosen

Abstract

The subject matter disclosed herein is generally directed to detecting and modulating novel gene signatures for the treatment and prognosis of cancer. The novel gene signatures predict overall survival in cancer and can be targeted therapeutically.

Date Published
Published Patent Application
WO2018/183921